KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Neogenomics (NEO) Other Operating Expenses: 2009-2024

Historic Other Operating Expenses for Neogenomics (NEO) over the last 16 years, with Dec 2024 value amounting to $91.3 million.

  • Neogenomics' Other Operating Expenses rose 34.86% to $28.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $119.7 million, marking a year-over-year increase of 44.37%. This contributed to the annual value of $91.3 million for FY2024, which is 28.89% up from last year.
  • Latest data reveals that Neogenomics reported Other Operating Expenses of $91.3 million as of FY2024, which was up 28.89% from $70.8 million recorded in FY2023.
  • In the past 5 years, Neogenomics' Other Operating Expenses registered a high of $91.3 million during FY2024, and its lowest value of $47.9 million during FY2020.
  • Its 3-year average for Other Operating Expenses is $76.5 million, with a median of $70.8 million in 2023.
  • Data for Neogenomics' Other Operating Expenses shows a peak YoY surged of 30.78% (in 2021) over the last 5 years.
  • Over the past 5 years, Neogenomics' Other Operating Expenses (Yearly) stood at $47.9 million in 2020, then skyrocketed by 30.78% to $62.6 million in 2021, then grew by 7.55% to $67.3 million in 2022, then grew by 5.23% to $70.8 million in 2023, then climbed by 28.89% to $91.3 million in 2024.